Profile
Sector:
HealthcareCountry:
CanadaIPO:
Website:
http://www.fsdpharma.comNext earnings report:
14 November 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Wed, 18 Sep 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
Included in screeners
What type of business is Quantum BioPharma?
Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd., is headquartered in Toronto, Canada.
What sector is Quantum BioPharma in?
Quantum BioPharma is in the Healthcare sector
What industry is Quantum BioPharma in?
Quantum BioPharma is in the Drug Manufacturers - Specialty & Generic industry
What country is Quantum BioPharma from?
Quantum BioPharma is headquartered in Canada
What is Quantum BioPharma website?
https://www.fsdpharma.com
Is Quantum BioPharma in the S&P 500?
No, Quantum BioPharma is not included in the S&P 500 index
Is Quantum BioPharma in the NASDAQ 100?
No, Quantum BioPharma is not included in the NASDAQ 100 index
Is Quantum BioPharma in the Dow Jones?
No, Quantum BioPharma is not included in the Dow Jones index
When was Quantum BioPharma the previous earnings report?
No data
When does Quantum BioPharma earnings report?
The next expected earnings date for Quantum BioPharma is 14 November 2024